findmyKOL
Clinical trialNCT01811212CompletedPhase 2Interventional

Cabozantinib-S-Malate in Treating Patients With Refractory Thyroid Cancer

SponsorNational Cancer Institute (NCI)Enrollment25Poorly Differentiated Thyroid Gland CarcinomaRecurrent Thyroid Gland CarcinomaStage I Thyroid Gland Follicular CarcinomaStage I Thyroid Gland Papillary CarcinomaStage II Thyroid Gland Follicular CarcinomaStage II Thyroid Gland Papillary Carcinoma+10 more conditions
View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Medstar Georgetown University Hospital

    Washington D.C., District of Columbia, United States

  • Mayo Clinic in Florida

    Jacksonville, Florida, United States

  • University of Chicago Comprehensive Cancer Center

    Chicago, Illinois, United States

  • Massachusetts General Hospital Cancer Center

    Boston, Massachusetts, United States

  • Mayo Clinic

    Rochester, Minnesota, United States

  • Ohio State University Comprehensive Cancer Center

    Columbus, Ohio, United States

  • M D Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
8 May 2013
Primary completion
13 Jul 2015
Completion
9 Oct 2017
Last update posted
3 Apr 2018
Registered enrollment
25
Registry id
NCT01811212
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.